Contract for MIDOSTAURIN (RYDAPT) 25 mg Capsules
A Contract Award Notice
by NORTHERN HEALTH AND SOCIAL CARE TRUST
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £180K
- Sector
- HEALTH
- Published
- 30 Aug 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Northern Ireland:
Geochart for 1 buyers and 1 suppliers
1 buyer
1 supplier
- Novartis Pharmaceuticals London
Description
Contract for supply of MIDOSTAURIN (RYDAPT) 25 mg Capsules for three years
Award Detail
| 1 | Novartis Pharmaceuticals (London)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Northern Trust requires the purchase of MIDOSTAURIN which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-03f806
- FTS 025463-2023